JENA WEISSENBURGER: Open Payments
NPI 1063198760 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 61 payments from 12 companies in 2025. Trend: 2023 $693 · 2024 $2,647 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $343 |
| Lundbeck LLC | 10 | $190 |
| ABBVIE INC. | 10 | $188 |
| Tris Pharma Inc | 18 | $166 |
| Axsome Therapeutics, Inc. | 1 | $75 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Neos Therapeutics, LP | 2 | $33 |
| Corium, LLC | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Dyanavel XR, Auvelity, Quviviq, FANAPT, Azstarys.
Industry payments across IA — which companies pay providers there.
